Registrar Corp, a global leader in regulatory and compliance technology solutions and a Paine Schwartz Partners portfolio company, has announced the acquisition of CMC Medical Devices (CMC), a Spain-based consultancy specializing in medical device and in vitro diagnostic (IVD) regulatory compliance. This strategic acquisition combines Registrar Corp’s worldwide network with CMC’s deep regulatory and clinical expertise, forming a comprehensive compliance partner to help manufacturers bring innovative healthcare products to global markets with greater speed and assurance.
“We’re delighted to welcome CMC Medical Devices into the Registrar Corp group,” said Raj Shah, CEO of Registrar Corp. “Together, we can provide a single, trusted source for medical device companies to navigate complex international regulations and access key markets across the U.S., Europe, and beyond.”
Echoing this sentiment, Manuel Mateos, CEO of CMC Medical Devices, said, “Becoming part of Registrar Corp allows us to extend our reach and deliver even greater value to our clients. Our combined mission is to help manufacturers bring safe, compliant products to patients faster and more efficiently.”
The acquisition marks a major expansion of Registrar Corp’s service portfolio, greatly extending its global reach and capabilities. The company now provides authorized representative and sponsor services across key international markets, including the European Union, United Kingdom, Switzerland, Australia, the United States, and China. This enhanced presence strengthens Registrar Corp’s ability to support clients with comprehensive regulatory representation worldwide.
In addition, the integration enables streamlined market access and export facilitation through end-to-end management of Free Sale Certificates (FSCs). This service accelerates product registration and approval processes across multiple jurisdictions, allowing manufacturers to bring their products to international markets more efficiently and with reduced administrative burden.
The acquisition also enhances Registrar Corp’s clinical and regulatory support capabilities by incorporating CMC’s well-established clinical network. Clients now benefit from expert assistance in documentation, data planning, post-market follow-up, and compliance with evolving MDR and IVDR requirements. Together, these expanded resources position Registrar Corp as a full-spectrum global partner for regulatory, clinical, and market entry solutions. With this integration, Registrar Corp strengthens its role as a one-stop compliance partner, helping manufacturers cut through regulatory complexity while reducing costs and time to market.
Registrar Corp supports over 32,000 clients in 190 countries, offering regulatory, compliance, and technology solutions for industries including medical devices, food and beverages, cosmetics, and OTC pharmaceuticals. CMC Medical Devices is a Spain-based consulting firm providing regulatory, clinical, and compliance guidance to medical device and IVD manufacturers across 70+ countries, with specialized expertise in MDR and IVDR implementation, market access, and authorized representation.
